Your browser doesn't support javascript.
loading
Neutralizing Activity against BQ.1.1, BN.1, and XBB.1 in Bivalent COVID-19 Vaccine Recipients: Comparison by the Types of Prior Infection and Vaccine Formulations.
Hyun, Hak-Jun; Choi, Min-Joo; Nham, Eliel; Seong, Hye; Yoon, Jin-Gu; Noh, Ji-Yun; Cheong, Hee-Jin; Kim, Woo-Joo; Yoon, Sun-Kyung; Park, Se-Jin; Gwak, Won-Seok; Lee, June-Woo; Kim, Byoung-Guk; Song, Joon-Young.
Afiliación
  • Hyun HJ; Department of Infectious Diseases, Ajou University School of Medicine, Suwon 16499, Republic of Korea.
  • Choi MJ; Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon 22711, Republic of Korea.
  • Nham E; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Seong H; Asia Pacific Influenza Institute, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Yoon JG; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul 02841, Republic of Korea.
  • Noh JY; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Cheong HJ; Asia Pacific Influenza Institute, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Kim WJ; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul 02841, Republic of Korea.
  • Yoon SK; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Park SJ; Asia Pacific Influenza Institute, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Gwak WS; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul 02841, Republic of Korea.
  • Lee JW; Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Kim BG; Asia Pacific Influenza Institute, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Song JY; Vaccine Innovation Center-KU Medicine (VIC-K), Seoul 02841, Republic of Korea.
Vaccines (Basel) ; 11(8)2023 Aug 04.
Article en En | MEDLINE | ID: mdl-37631890
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article